Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fitzpatrick

Showing results (41-50 of 1,267) with videos related to

Pageof 127
Sort By:
BJU International|December 11, 2012
BJUI editor's commentJohn M Fitzpatrick
BJU International|March 13, 2009
BJU International. Editor's CommentJohn M Fitzpatrick
Journal of Evolutionary Biology|November 21, 2007
Dobzhansky-Muller model of hybrid dysfunction supported by poor burst-speed performance in hybrid tiger salamandersB M Fitzpatrick
BJU International|June 28, 2007
Is hormone ablation still the right choice for advanced prostate cancer?John M Fitzpatrick
Annals of the American Thoracic Society|December 30, 2017
Out of One, Many: Moving beyond a Single Guideline toward Personalized Asthma Care for Obese ChildrenAnne M Fitzpatrick
British Journal of Urology|May 20, 1998
A critical evaluation of technological innovations in the treatment of symptomatic benign prostatic hyperplasiaJ M Fitzpatrick
Medical Economics|August 5, 2006
What's a fact witness?John M Fitzpatrick
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2020
Ancient aquaculture and the rise of social complexityScott M Fitzpatrick
Irish Medical Journal|February 26, 1999
Current management and future trends in benign prostatic hyperplasia (BPH)J M Fitzpatrick
European Urology|January 1, 1996
Combined androgen blockade is the treatment of choice for patients with advanced prostate cancer: the argument againstJ M Fitzpatrick
Pageof 127

Showing results (41-50 of 1,267) with videos related to

Sort By:
Pageof 127
BJU International|December 11, 2012
BJUI editor's commentJohn M Fitzpatrick
BJU International|March 13, 2009
BJU International. Editor's CommentJohn M Fitzpatrick
Journal of Evolutionary Biology|November 21, 2007
Dobzhansky-Muller model of hybrid dysfunction supported by poor burst-speed performance in hybrid tiger salamandersB M Fitzpatrick
BJU International|June 28, 2007
Is hormone ablation still the right choice for advanced prostate cancer?John M Fitzpatrick
Annals of the American Thoracic Society|December 30, 2017
Out of One, Many: Moving beyond a Single Guideline toward Personalized Asthma Care for Obese ChildrenAnne M Fitzpatrick
British Journal of Urology|May 20, 1998
A critical evaluation of technological innovations in the treatment of symptomatic benign prostatic hyperplasiaJ M Fitzpatrick
Medical Economics|August 5, 2006
What's a fact witness?John M Fitzpatrick
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2020
Ancient aquaculture and the rise of social complexityScott M Fitzpatrick
Irish Medical Journal|February 26, 1999
Current management and future trends in benign prostatic hyperplasia (BPH)J M Fitzpatrick
European Urology|January 1, 1996
Combined androgen blockade is the treatment of choice for patients with advanced prostate cancer: the argument againstJ M Fitzpatrick
Pageof 127